21 Instituto de Medicina Molecular Joao Lobo Antunes
The Instituto de Medicina Molecular João Lobo Antunes (iMM) is a leading Portuguese research institution integrated in the Lisbon Academic Medical Centre, alongside the Faculty of Medicine of the University of Lisbon and the largest hospital in the country, Hospital Santa Maria. iMM hosts over 500 researchers and fosters disruptive discoveries across biomedical research lines.
Main tasks in the project
iMM will be a will be a central site for the validation of the identified digital endpoints and recruitment of PD and HD patients in IDEA-FAST. iMM aims to collaborate in the clinically-adapted design of both part A pilot study and part B clinical validation study to be developed, preparing the study documentation and helping to manage any clinically relevant ethical aspects associated with the digital devices testing to be conducted in IDEA-FAST in compliance with GDPR, EMA and FDA guidance. These tasks result from our previous research expertise, project participation and the daily care environment represented at iMM.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.